Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (251-260 of 822) with videos related to

Pageof 83
Sort By:
Thoracic Cancer|June 28, 2018
Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastasesYing Zhu, Lei Fu, Wang Jing, et al.
Cancer Letters|July 10, 2017
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challengesXiangjiao Meng, Yanli Liu, Jianjun Zhang, et al.
Oncotarget|December 31, 2016
The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based studyHaiyong Wang, Chenyue Zhang, Jingze Zhang, et al.
Oncology Letters|January 2, 2016
Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancerPengyue Shi, Xue Meng, Mengmeng Ni, et al.
Frontiers in Oncology|June 3, 2021
Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung CancerJi Li, Wang Jing, Wenxiao Jia, et al.
Cancer Communications (London, England)|October 26, 2021
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutationLin Ma, Bowen Diao, Zhaoqin Huang, et al.
Frontiers in Oncology|April 1, 2021
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non-Small-Cell Lung Cancer After Previous Systemic Treatment Failure-A Retrospective StudyPeiliang Wang, Xiaozhuang Fang, Tianwen Yin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
Skull Dosimetry for Mitigating Acute Hematologic Toxicity in NSCLC Patients with Brain Metastases Undergoing Cranial Radiotherapy and ImmunotherapyJiachun Ma, Hongxuan Yu, Xiao Zhang, et al.
Cancer Letters|January 29, 2025
Thyroxine alleviates interstitial lung disease induced by combined radiotherapy and immunotherapyYou Mo, Yiwei Qin, Pengwei Li, et al.
Journal of Applied Clinical Medical Physics|January 17, 2024
Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registrationShaozhuang Zhai, Ziwen Wei, Xiaolong Wu, et al.
Pageof 83

Showing results (251-260 of 822) with videos related to

Sort By:
Pageof 83
Thoracic Cancer|June 28, 2018
Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastasesYing Zhu, Lei Fu, Wang Jing, et al.
Cancer Letters|July 10, 2017
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challengesXiangjiao Meng, Yanli Liu, Jianjun Zhang, et al.
Oncotarget|December 31, 2016
The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based studyHaiyong Wang, Chenyue Zhang, Jingze Zhang, et al.
Oncology Letters|January 2, 2016
Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancerPengyue Shi, Xue Meng, Mengmeng Ni, et al.
Frontiers in Oncology|June 3, 2021
Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung CancerJi Li, Wang Jing, Wenxiao Jia, et al.
Cancer Communications (London, England)|October 26, 2021
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutationLin Ma, Bowen Diao, Zhaoqin Huang, et al.
Frontiers in Oncology|April 1, 2021
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non-Small-Cell Lung Cancer After Previous Systemic Treatment Failure-A Retrospective StudyPeiliang Wang, Xiaozhuang Fang, Tianwen Yin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
Skull Dosimetry for Mitigating Acute Hematologic Toxicity in NSCLC Patients with Brain Metastases Undergoing Cranial Radiotherapy and ImmunotherapyJiachun Ma, Hongxuan Yu, Xiao Zhang, et al.
Cancer Letters|January 29, 2025
Thyroxine alleviates interstitial lung disease induced by combined radiotherapy and immunotherapyYou Mo, Yiwei Qin, Pengwei Li, et al.
Journal of Applied Clinical Medical Physics|January 17, 2024
Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registrationShaozhuang Zhai, Ziwen Wei, Xiaolong Wu, et al.
Pageof 83